<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A 64-year-old man was admitted to hospital with increasing <z:hpo ids='HP_0001250'>seizure</z:hpo> frequency, <z:hpo ids='HP_0001254'>lethargy</z:hpo> and <z:hpo ids='HP_0001289'>confusion</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>He had a history of <z:hpo ids='HP_0007417'>discoid lupus erythematosus</z:hpo>, <z:hpo ids='HP_0002384'>complex partial seizures</z:hpo>, <z:e sem="disease" ids="C0079102" disease_type="Disease or Syndrome" abbrv="">cerebral thromboses</z:e> associated with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>After admission to hospital, he developed <z:hpo ids='HP_0001890'>autoimmune hemolytic anemia</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, severe <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0000093'>proteinuria</z:hpo> and a fluctuating level of consciousness </plain></SENT>
<SENT sid="3" pm="."><plain>INVESTIGATIONS: Physical examination, biochemical and hematological indices, urine dipstick, electrocardiography and chest radiography on admission, with subsequent electroencephalography, lumbar puncture, septic screen, autoimmune screen, CT of the head, MRI of the brain and renal biopsy </plain></SENT>
<SENT sid="4" pm="."><plain>DIAGNOSIS: Conversion of <z:hpo ids='HP_0007417'>discoid lupus erythematosus</z:hpo> with APS to <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> with APS </plain></SENT>
<SENT sid="5" pm="."><plain>MANAGEMENT: Pulsed intravenous <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> and a single infusion of intravenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, followed by oral <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, were initially administered for presumed <z:e sem="disease" ids="C0393968" disease_type="Disease or Syndrome" abbrv="">cerebral lupus</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>When renal biopsy revealed dual pathology, another dose of intravenous <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> was administered with intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy to treat <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and APS, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Intravenous immunoglobulin was used to treat <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, which was unresponsive to immunosuppression and anticoagulation </plain></SENT>
<SENT sid="8" pm="."><plain>Gradual improvement occurred with maximal <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> therapy and supportive treatment </plain></SENT>
<SENT sid="9" pm="."><plain>The patient was discharged after 9 months of hospital treatment </plain></SENT>
<SENT sid="10" pm="."><plain>His medication at this stage included <z:chebi fb="8" ids="10033">warfarin</z:chebi>, <z:chebi fb="0" ids="37941">clopidogrel</z:chebi>, <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, carbamazepine, <z:chebi fb="0" ids="8774">ramipril</z:chebi>, atenolol, calcium and <z:chebi fb="27" ids="27300">vitamin D</z:chebi> supplements, and <z:chebi fb="0" ids="2567">alendronate</z:chebi> </plain></SENT>
</text></document>